EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cardiometabolic monitoring in children and adolescents prescribed antipsychotics in Australian primary care, 2011 to 2017

Julie Klau iD, David Gonzalez-Chica iD, Melissa Raven iD, Natalie Aboustate iD, Jon Jureidini iD

Australian & New Zealand Journal of Psychiatry · 2025

DOI: 10.1177/00048674251361696 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian & New Zealand Journal of Psychiatry, 2025. Verfasst von Julie Klau und 4 weiteren Autor:innen. Beteiligte Einrichtung: Critical and Ethical Mental Health Research Group, Robinson Research Institute, Faculty of Health and Medical Sciences, The University of Adelaide, A…. Hauptthemen laut MEDLINE: Antipsychotic Agents, Primary Health Care, Metabolic Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Channel 7 Children’s Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine the extent of cardiometabolic monitoring occurring in children/adolescents 18 years and under receiving antipsychotics in Australian general practice: study period 2011 to 2017.

Methods

Retrospective cohort study using large primary care database, MedicineInsight. Rates of monitoring within 12 months of patients receiving an incident antipsychotic prescription were reported descriptively for weight, body mass index (BMI), waist circumference (WC), glucose, total cholesterol, triglycerides, high-density lipoproteins (HDL), blood pressure, liver function, prolactin, and metabolic syndrome (MetS) defined as weight, blood pressure and glucose. Target trial methodology was used to examine whether monitoring rates were higher in patients prescribed antipsychotics compared to patients not receiving antipsychotics.

Results

55.9% of patients using antipsychotics were monitored at least once on at least one parameter. Weight was most frequently measured (39.1% patients measured at least once), followed by BMI (31.2%), blood pressure (29.0%), glucose (12.9%), liver function (9.1%), total cholesterol (8.1%), triglycerides (6.7%), HDL (3.1%), WC (1.6%) and prolactin (1.1%). Monitoring for MetS occurred at least once in 1.5% of patients. Antipsychotic users recorded a small but significantly higher rate of monitoring than non-users (1.157 vs 0.691 monitoring visits for any parameter within the 12 month measurement period, difference 0.461; 95% CI [0.271, 0.660], p < 0.001).

Conclusion

Rates of cardiometabolic monitoring were well below guideline recommendations. Our results suggest the need for education and training to increase awareness of adverse health impacts of antipsychotics and improve adherence to cardiometabolic guideline recommendations. Communication between primary and secondary health care providers also needs to be addressed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antipsychotic AgentsPrimary Health CareMetabolic SyndromeHumansAdolescentChildMaleFemaleAustraliaRetrospective StudiesBlood GlucoseBlood PressureBody Mass Index

Stichwörter der Autor:innen

Antipsychoticsadolescentschildrenmetabolic monitoringmetabolic syndrome

Substanzen

Antipsychotic AgentsBlood Glucose

Autor:innen und Institutionen

  • Critical and Ethical Mental Health Research Group, Robinson Research Institute, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.
  • Discipline of General Practice, Adelaide Medical School, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, SA, Australia.

ORCID-Profile: Julie Klau, David Gonzalez-Chica, Melissa Raven, Natalie Aboustate, Jon Jureidini

Förderung

  • Channel 7 Children’s Research Foundation

Zitieren

APA

Klau, J., Gonzalez-Chica, D., Raven, M., Aboustate, N., & Jureidini, J. (2025). Cardiometabolic monitoring in children and adolescents prescribed antipsychotics in Australian primary care, 2011 to 2017. Australian & New Zealand Journal of Psychiatry. https://doi.org/10.1177/00048674251361696

Vancouver

Klau J, Gonzalez-Chica D, Raven M, Aboustate N, Jureidini J. Cardiometabolic monitoring in children and adolescents prescribed antipsychotics in Australian primary care, 2011 to 2017. Australian & New Zealand Journal of Psychiatry. 2025. doi:10.1177/00048674251361696

BibTeX
@article{Klau2025,
  author = {Klau, Julie and Gonzalez-Chica, David and Raven, Melissa and Aboustate, Natalie and Jureidini, Jon},
  title = {Cardiometabolic monitoring in children and adolescents prescribed antipsychotics in Australian primary care, 2011 to 2017},
  journal = {Australian & New Zealand Journal of Psychiatry},
  year = {2025},
  doi = {10.1177/00048674251361696}
}
Kostenlos starten →